Anhui Fengyuan Pharmaceutical Co.,Ltd.’s Net Profit Rose 3.6% in First Half of 2023

Anhui Fengyuan Pharmaceutical Co.,Ltd. (安徽丰原药业股份有限公司) (000153.SZ) reported a net profit of 102.3 million yuan in the first half of 2023, up 3.6% year-on-year.

Meanwhile, the company posted 2.3 billion yuan in revenue, up 16.7% year-on-year.

At the end of the reporting period, it had 4.4 billion yuan in total assets and 2.6 billion yuan in total liabilities, with a liability-to-asset ratio of 58.4%.